Semaglutide reduces appetite by activating GLP-1 receptors in the brain, helping patients lose an average of 1522% of body weight over 68 weeks according to clinical trials
This means it mimics the effects of the GLP-1 hormone to help regulate blood sugar levels and reduce appetite, he says
Weight loss treatment is coordinated with your primary care provider to ensure it aligns with your overall health and existing medical conditions
Nauseathe most common early side effectoccurs when tirzepatide activates GLP-1 receptors in the brain and gastrointestinal tract
Over time, the darker, pigmented cells on the surface are shed away, and the newer, more even-toned cells take their place
But for many people, the biggest financial needle mover isnt cost-effectiveness